Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of... ( EMERYVILLE Calif. April 30 /- Neu...)

Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine

Date:4/30/2008

EMERYVILLE, Calif., April 30 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NTI(R)) (Nasdaq: NTII), today announced it has received approximately $2.0 million from Merz Pharmaceuticals GmbH (Merz) for sales by Merz and its marketing partners of Memantine for the treatment of moderate-to-severe Alzheimer's disease during the quarter ended December 31, 2007. Under an exclusive marketing agreement, NTI currently receives quarterly royalty payments on certain sales of Memantine by Merz and its marketing partners.

About Neurobiological Technologies, Inc.

Neurobiological Technologies, Inc, (Nasdaq: NTII) is a biopharmaceutical company focused on developing novel, first-in-class agents for central nervous system conditions and other serious unmet medical needs. The Company's most advanced product candidate, Viprinex(TM) (ancrod), is in phase 3 clinical testing as a novel investigational drug for treating acute ischemic stroke. Viprinex has multiple mechanisms of action and is specifically designed to double the time period that patients can be treated after the onset of a stroke. Acute ischemic stroke is one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. NTI's pipeline also includes a phase 3 investigational drug for brain swelling and other drug candidates in early-stage development for Alzheimer's and Huntington's diseases.

SOURCE Neurobiological Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:6/18/2013)... 2013 PathoGenetix, Inc. , ... rapid bacterial strain typing, announced today that John ... as Vice President of Engineering. Dr. Luckey will ... RESOLUTION™ Microbial Genotyping System . The fully ... pathogen-specific assay kits, database and software, will be ...

(Date:6/18/2013)... DC (PRWEB) June 18, 2013 On ... Services (CMS) released a final decision memorandum concluding ... to guide subsequent management of anti-tumor strategy, and ... collection. The National Oncological PET Registry (NOPR) was developed ... the first projects under the Coverage with Evidence Development ...

(Date:6/17/2013)... MA (PRWEB) June 17, 2013 ... system in March that helps better monitor potentially harmful ... The microAnalyzer V2.0, which was developed by Draper ... Space Station. , Astronauts breathe air that is processed ... to harmful compounds in the air, even in trace ...

(Date:6/17/2013)... 2013 The Defense Threat Reduction Agency ... at the Waterford in Springfield, Virginia on July 22-25 ... will present technical details on their counter weapons of ... broad range of counter WMD areas including: (1) Science ... Science; (3) Science for Protection; (4) Science to Defeat ...

Breaking Biology Technology:PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 2 PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System 3 WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 2 WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data 3 New Monitoring System Will Better Protect NASA Astronauts on ISS 2 Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review 2

[0] PathoGenetix Hires Technology Development VP for Resolution Microbial Genotyping System [0] WMIS Welcomes CMS Decision: Expanding Coverage for FDG-PET and Ending NOPR Data [0] New Monitoring System Will Better Protect NASA Astronauts on ISS [0] Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review

... 2007 -, - Tests Delivered Grew 68 Percent Compared to ... - Conference Call Today at ... Health,Inc. (Nasdaq: GHDX ) today reported financial results and business progress,for ... million in the first quarter of 2008,compared to $14.1 million in the ...

... Pfizer Enterprise 2.0 expert, to deliver keynote address ... ... Pa., May 6 Simon Revell, Manager of Enterprise,2.0 Technology ... Web 2.0,social software can be leveraged to stimulate the advancement ...

... Awards with ,Blue Ladies, a, Masterpiece of a ... CHICAGO, May 6 AbelsonTaylor, long known ... top honors in the medical device category at ... awards ceremony was part of,the DTC National Conference ...

Genomic Health Announces First Quarter 2008 Financial Results and Business Progress Hershey Center for Applied Research Supports Acceleration of Scientific Research and Development AbelsonTaylor Captures DTC Gold

(Date:6/18/2013)... $12.7 million to match nine academic research groups ... explore new treatments for patients in eight disease ... schizophrenia. The collaborative pilot initiative, called Discovering New ... the National Center for Advancing Translational Sciences (NCATS) ... The process of developing a new therapeutic is ...

(Date:6/18/2013)... chemical modification of DNA and this modification can ... sequence. Until now, scientists believed that this epigenetic ... Today, a team of researchers from the University ... Louis-Jeantet Professor at the Faculty of Medicine, reveals ... that DNA methylation may play both a passive ...

(Date:6/17/2013)... new virus in patients with severe brain infections in ... virus is responsible for the symptoms of disease. , ... out of 644 patients with severe brain infections in ... any of the 122 patients with non-infectious brain disorders ... central nervous system are often fatal and patients who ...

Breaking Biology News(10 mins):NIH to fund collaborations with industry to identify new uses for existing compounds 2 NIH to fund collaborations with industry to identify new uses for existing compounds 3 NIH to fund collaborations with industry to identify new uses for existing compounds 4 The secret of DNA methylation 2 New virus isolated from patients with severe brain infections 2 New virus isolated from patients with severe brain infections 3

[0] NIH to fund collaborations with industry to identify new uses for existing compounds [0] The secret of DNA methylation [0] New virus isolated from patients with severe brain infections

... Charlie Kerfoot,s doughnut, and all fingers point to a European ... No one knew about the doughnut in southern Lake Michigan, ... Charles Kerfoot and his research team first saw it in ... their research vessels on any of the shipwreck-studded Great Lakes ...

... 17, 2010Colon cancer is the second most common cancer in ... year. It has been known for some time that mutations ... of all sporadic colon cancers. Now researchers at Huntsman Cancer ... featured today in Cell the mechanism by which mutation of ...

... We run our modern lives largely by the clock, from ... herald each new workday to the watches and clocks that ... the like. In addition to those ubiquitous timekeepers, ... biological machinery and which help set our circadian rhythms, regulating ...

Cached Biology News:Death of the 'doughnut' 2 Death of the 'doughnut' 3 Mechanism behind demethylation pinpointed in APC gene mutants 2 Tick tock: Rods help set internal clocks, biologist says 2

Death of the 'doughnut'Mechanism behind demethylation pinpointed in APC gene mutants Tick tock: Rods help set internal clocks, biologist says

Mouse monoclonal antibody raised against a full length recombinant PPIL2. NCBI Entrez Gene ID = PPIL2...

Mouse monoclonal antibody raised against a full length recombinant SCGB3A2. NCBI Entrez Gene ID = SCGB3A2...

Mouse polyclonal antibody to BAG2 - BCL2-associated athanogene 2...

Mouse monoclonal antibody raised against a partial recombinant QPCT. NCBI Entrez Gene ID = QPCT...

Biology Products:

Mouse Anti-Human PPIL2 Monoclonal Antibody, Unconjugated, Clone 2E11 from Abnova Corporation Mouse Anti-Human SCGB3A2 Monoclonal Antibody, Unconjugated, Clone 1B2 from Abnova Corporation Mouse Anti-Human BAG2 Polyclonal Antibody, Unconjugated from Novus Biologicals Mouse Anti-Human QPCT Monoclonal Antibody, Unconjugated, Clone 4E11 from Abnova Corporation